Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

…

04 April 2025 Imfinzi-based perioperative regimen approved in the EU for resectable non-small cell lung cancer  Approval based on AEGEAN Phase III trial…

04 April 2025 Enhertu approved in the EU as first HER2-directed therapy for patients with HR-positive, HER2-low or HER2-ultralow metastatic breast cancer…

As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on Wednesday decimated the…

International pharma stocks GSK PLC (LSE:GSK, NYSE:GSK) and AstraZeneca PLC (LSE:AZN) may have dodged a bullet under Donald Trump’s sweeping new tariff...…

UK pharmaceutical giants AstraZeneca PLC (LSE:AZN) and GSK PLC (LSE:GSK, NYSE:GSK) shares both avoided the wider sell-off on Thursday morning on hopes that...…

AstraZenecas new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.…

31 March 2025 Calquence plus chemoimmunotherapy recommended for approval in the EU by CHMP as first and only BTK inhibitor for 1st-line…

31 March 2025 Imfinzi approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer  Based on NIAGARA Phase III…

…

Dividend investing is an excellent strategy for (at least) two reasons. Companies that can provide consistent payouts generally have robust…

The average brokerage recommendation (ABR) for Astrazeneca (AZN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street…

In the most recent trading session, Astrazeneca (AZN) closed at $72.72, indicating a -0.45% shift from the previous trading day.…

The tech-heavy Nasdaq Composite index recently entered correction territory. Though it was able to climb out of it, equities broadly…

Pharmaceutical company will invest money over five years in ‘strategic partnership’ with the city’s authorities…